Orbimed advisors buys Adicet Bio (ACET) shares worth $5 million
PositiveFinancial Markets

Orbimed Advisors has made a significant investment by purchasing $5 million worth of shares in Adicet Bio, a move that highlights confidence in the biotech company's potential. This acquisition not only strengthens Orbimed's portfolio but also signals optimism about Adicet's future developments in the biopharmaceutical sector, which could lead to advancements in treatments and therapies.
— Curated by the World Pulse Now AI Editorial System